AzTrials
AzTrials

Color Reaction With Amniotic FluidNCT01022814

Development of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine

An observational study of Color Reaction With Amniotic Fluid, run by Hadassah Medical Organization at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the final months of pregnancy, women need to know whether their 'water is broken' necessitating a race to the delivery room, or whether pressure of the foetus on their bladder has caused them merely to pass urine. They may also have faced the same dilemma on many occasions much earlier in the pregnancy. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Color Reaction With Amniotic Fluid
What is being tested?
A disposable pad containing sensitive chemical indicators
Type of treatment
Medical device
How many people
300 participants
Where
1 siteIsrael
Study dates
Jan 2010to Jan 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: An unrecognized amniotic fluid that passed a genetic analysis and appointed to be disposed.

Who may be able to join

  • Amniotic fluid that were taken after the 17th week.

Who cannot join

  • None.

Trial locations and contacts

1 site in 1 country.

Nili Yanai, Dr' contact

050-7874559

yanaio@netvision.net.il

Israel1 site
  • Hadassah Medical Organization

    Jerusalem

    Arik Tzukert, DMD, 00 972 2 6776095, arik@hadassah.org.il

    Nili Yanai, Dr'

Other trials in Israel

About this study

In the final months of pregnancy, women need to know whether their 'water is broken' necessitating a race to the delivery room, or whether pressure of the foetus on their bladder has caused them merely to pass urine. They may also have faced the same dilemma on many occasions much earlier in the pregnancy. With this development the investigators will provide them with an immediate answer to this critical question.

Being tested
A disposable pad containing sensitive chemical indicators

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A disposable pad containing sensitive chemical indicatorsDevice

    After a urine/amniotic fluid leaking, liquid meets the diagnostic device and chemical reactions will occur in the test zones and cause a color change.

Study groups in NCT01022814
Study groupRoleWhat they receive
Pregnant womanNot described
Receives: Device: A disposable pad containing sensitive chemical indicators

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2009 (estimated)
  2. Study startJan 2010
  3. Primary completionJan 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01022814
Sponsor's protocol ID
Momteclife-HMO-CTIL
Status last verified
Nov 2009
First submitted
26 Nov 2009
Last updated
1 Dec 2009
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Color Reaction With Amniotic Fluid, run by Hadassah Medical Organization at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nili Yanai, Dr' (050-7874559, yanaio@netvision.net.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in